Role of HbA1c in Predicting Adverse Pregnancy Outcomes

Recruiting now

Conditions studied: Gestational Diabetes

In brief

This study aims to determine the reference value of HbA1c that can be used to predict adverse pregnancy outcomes. These adverse outcomes include LGA fetus, shoulder dystocia, caesarean section, pre-term birth, pre-eclampsia and fetal neonatal hypoglycaemia.

Key facts

Study ID

NCT06676254

Run by

National University of Malaysia

People needed

195

Starts

2024-06-27

Expected to finish

2026-06-26

Last updated by the study team

2024-11-06

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Pregnant woman with singleton pregnancy
• Confirmed diagnosis of GDM based on Malaysia CPG (≥5.1/7.8)
• HbA1c level taken at least once at any time during the pregnancy
• Delivery after 28 weeks gestation

You may not qualify if…

• Major fetal anomaly
• Haemoglobin level of ≤9 g/dL (moderate or severe anaemia in pregnancy)
• Women with autoimmune diseases
• Overt diabetes or pre-existing diabetes

Where it is running

• Department of Obstetrics & Gynaecology, Hospital Canselor Tuanku Muhriz — Cheras, Kuala Lumpur, Malaysia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.